Quinoline compounds suitable for treating disorders that respond to modulation of the serotonin 5-HT6 receptor

The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT

Saved in:
Bibliographic Details
Main Authors TURNER, SEAN COLM, WICKE, KARSTEN, BRAJE, WILFRIED, HAUPT, ANDREAS, LANGE, UDO, DRESCHER, KARLA, UNGER, LILIANE, WERNET, WOLFGANG, MEZLER, MARIO, MAYRER, MATTHIAS
Format Patent
LanguageEnglish
Published 05.09.2013
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to novel quinoline compounds of the formula (I) and to the salts thereof. The compounds possess valuable therapeutic properties and are particularly suitable, for treating diseases that respond to modulation of the serotonin 5-HT
Bibliography:Application Number: AU20080285652